IA
KMTS

IFP Advisors’s Kestra Medical Technologies KMTS Stock Holding History

IFP Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483 Buy
19
+1
+6% +$21 ﹤0.01% 4693
2026
Q1 		$359 Hold
18
– – ﹤0.01% 4501
2025
Q4 		$477 Hold
18
– – ﹤0.01% 4294
2025
Q3 		$428 Buy
+18
New +$322 ﹤0.01% 4222

Other funds holding KMTS

AP
Andera Partners Paris $206M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
RA
RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

IFP Advisors's KMTS Position: Q2 2026 in Review

IFP Advisors increased its Kestra Medical Technologies (KMTS) stake by 5.6% in Q2 2026, buying an estimated $21 and bringing the position to 19 shares worth $483. The position accounts for ﹤0.01% of the portfolio, ranked #4693.

IFP Advisors first reported a position in KMTS in Q3 2025 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • IFP Advisors held 19 shares of Kestra Medical Technologies worth $483 as of Q2 2026.
  • IFP Advisors bought 1 Kestra Medical Technologies share in Q2 2026, an estimated $21.
  • Kestra Medical Technologies made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4693 holding.
  • IFP Advisors first reported a position in Kestra Medical Technologies in Q3 2025 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.